Autologous cell-based therapy for ischemic heart disease: Clinical evidence, proposed mechanisms of action, and current limitations

Catheterization and Cardiovascular Interventions

Volumn 73, Issue 3, 2009, Pages 281-288

  Perin, Emerson C ^a,b   Silva, Guilherme V ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Cardiac stem cell therapy; Coronary artery disease; Heart failure; Stem cells

Indexed keywords

VASCULOTROPIN;

ACUTE HEART INFARCTION; ANGIOGENESIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARDIOMEGALY; CARDIOMYOPATHY; CELL DIFFERENTIATION; CELL REGENERATION; CELL TYPE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG MECHANISM; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; ISCHEMIC HEART DISEASE; MYOBLAST; NONHUMAN; PARACRINE SIGNALING; PATIENT SAFETY; TISSUE REPAIR; TREATMENT RESPONSE;

CLINICAL TRIALS AS TOPIC; HUMANS; MYOCARDIAL ISCHEMIA; STEM CELL TRANSPLANTATION; TISSUE THERAPY; TRANSPLANTATION, AUTOLOGOUS;

EID: 65549104457     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21807     Document Type: Article

References (36)

1. Perin EC, Silva GV, Assad JA, Vela D, Buja LM, et al. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol 2008;44:486-495.
2. Perin EC, Silva GV. Stem cell therapy in end-stage ischemic heart failure: A catheter-based therapeutic strategy targeting myocardial viability. Eur Heart J Suppl 2007;8:H46-H51.
3. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003;361: 47-49.
4. Fuchs S, Satler LF, Kornowski R, Okubagzi P, Weisz G, et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: A feasibility study. J Am Coll Cardiol 2003;41:1721-1724.
5. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003;107:2294-2302.
6. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 2004;110(11 Suppl 1):II213-II218.
7. Stamm C, Kleine HD, Westphal B, Petzsch M, Kittner C, Nienaber CA, Freund M, Steinhoff G. CABG and bone marrow stem cell transplantation after myocardial infarction. Thorac Cardiovasc Surg 2004;52:152-158.
8. Erbs S, Linke A, Adams V, Lenk K, Thiele H, et al. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: First randomized and placebo-controlled study. Circ Res 2005;97:756-762.
9. Hendrikx M, Hensen K, Clijsters C, Jongen H, Koninckx R, et al. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: Results from a randomized controlled clinical trial. Circulation 2006;114(1 Suppl):I101-I107.
10. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002;106:3009-3017.
11. Jolicoeur EM, Granger CB, Fakunding JL, Mockrin SC, Grant SM, Ellis SG, Weisel RD, Goodell MA. Bringing cardiovascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, and Blood Institute Cell Therapy Working Group meeting. Am Heart J 2007;153:732-742.
12. Hagege AA, Marolleau JP, Vilquin JT, Alheritiere A, Peyrard S, et al. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation 2006;114(1 Suppl):I108-I113.
13. Herreros J, Prosper F, Perez A, Gavira JJ, Garcia-Velloso MJ, et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J. 2003;24:2012-2020.
14. Siminiak T, Fiszer D, Jerzykowska O, Grygielska B, Rozwadowska N, Kalmucki P, Kurpisz M. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: The POZNAN trial. Eur Heart J 2005;26:1188-1195.
15. Siminiak T, Kalawski R, Fiszer D, Jerzykowska O, Rzezniczak J, Rozwadowska N, Kurpisz M. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up. Am Heart J 2004;148:531-537.
16. Dib N, Michler RE, Pagani FD, Wright S, Kereiakes DJ, et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: Four-year follow-up. Circulation 2005;112:1748-1755.
17. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, Kogler G, Wernet P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-1918.
18. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 2004; 44:1690-1699.
19. Chen SL, Fang WW, Ye F, Liu YH, Qian J, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004;94:92-95.
20. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (Bone marrow transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006;113:1287-1294.
21. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 2004;364:141-148.
22. Fernandez-Aviles F, San Roman JA, Garcia-Frade J, Fernandez ME, Penarrubia MJ, et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004;95:742-748.
23. Zohlnhofer D, Ott I, Mehilli J, Schomig K, Michalk F, et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: A randomized controlled trial. JAMA 2006;295:1003-1010.
24. Kang HJ, Lee HY, Na SH, Chang SA, Park KW, et al. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: The MAGIC Cell-3-DES randomized, controlled trial. Circulation 2006;114(1 Suppl):I145-I151.
25. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial. Lancet 2006;367:113-121.
26. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355:1199-1209.
27. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-1221.
28. Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): Mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003;108:2212-2218.
29. Bartunek J, Vanderheyden M, Vandekerckhove B, Mansour S, De Bruyne B, De Bondt P, Van Haute I, Lootens N, Heyndrickx G, Wijns W. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: Feasibility and safety. Circulation 2005;112(9 Suppl):I178-I183.
30. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: The scientific foundations of cardiac repair. J Clin Invest 2005;115: 572-583.
31. Leri A, Kajstura J, Anversa P, Frishman WH. Myocardial regeneration and stem cell repair. Curr Probl Cardiol 2008;33:91-153.
32. Purhonen S, Palm J, Rossi D, Kaskenpaa N, Rajantie I, Yla-Herttuala S, Alitalo K, Weissman IL, Salven P. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci U S A 2008;105:6620-6625.
33. Shimada T, Takeshita Y, Murohara T, Sasaki K, Egami K, Shintani S, Katsuda Y, Ikeda H, Nabeshima Y, Imaizumi T. Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation 2004;110:1148-1155.
34. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005;45:1441-1448.
35. Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, Dimmeler S, Zeiher AM. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005;111:2981-2987.
36. Ballard VL, Edelberg JM. Stem cells for cardiovascular repair - The challenges of the aging heart. J Mol Cell Cardiol, 2008 doi:10.1016/ jyjmcc.2008.02.277.